GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 24, 2024

https://www.globenewswire.com/news-release/2024/01/24/2816106/0/en/GeneDx-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

STAMFORD, Conn., Jan. 24, 2024 (GLOBE NEWSWIRE) — GeneDx, a leader in delivering improved health outcomes through genomic and clinical insights, today announced that, effective as of January 23, 2024, the compensation committee of GeneDx’s board of directors granted newly hired employees 106,030 restricted stock units (“RSUs”) as inducements material to each employee entering into employment with GeneDx. The RSUs were granted under GeneDx’s 2023 Equity Inducement Plan and in accordance with Nasdaq Listing Rule 5635(c)(4).

Read more at globenewswire.com

Related news for (WGS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.